# Aurealis Therapeutics: Research, Kuopio, Finland

> Aurealis Therapeutics: Aurealis Therapeutics is a clinical-stage Swiss-Finnish synthetic biology company focused on developing curative multi-target cell...

Source: https://millionrounds.com/startup/aurealis-therapeutics (Millionrounds; every figure on the page links to its filing or article)

Finland · [Research startup](https://millionrounds.com/companies)

# Aurealis Therapeutics

Aurealis Therapeutics is a clinical-stage Swiss-Finnish synthetic biology company focused on developing curative multi-target cell and gene therapies.

Email

Funding reported Last round: Series unknown

Research Kuopio, Finland

Follow Aurealis Therapeutics and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Faurealis-therapeutics)

Company summary

- **Founded:** 2015 11 years old
- **Team:** 18 11 to 50 people
- **Funding reported:** 9M as listed, currency not stated
- **Last round:** Series unknown Nov 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Aurealis Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Aurealis Therapeutics

Aurealis Therapeutics is a clinical-stage Swiss-Finnish synthetic biology company focused on developing curative multi-target cell and gene therapies.

The company aims to address chronic wounds, deadly cancers, and inflammatory diseases using genetically modified lactic acid bacteria as a core platform. Founded in 2010 and operating from Kuopio, Finland, and Zug/Basel, Switzerland, Aurealis Therapeutics has raised approximately $40.3 million in funding. The company is advancing a pipeline of innovative therapies, including AUP-16, which is in Phase 2 clinical trials for chronic wounds, and AUP-55, a pre-clinical candidate targeting ovarian cancer and peritoneal carcinomatosis. Aurealis Therapeutics employs around 17 people and actively seeks strategic partnerships to facilitate market entry and commercialization of its therapies. The company is dedicated to creating impactful treatments for patients with high unmet medical needs in the healthcare sector.

## What company datasets say Aurealis Therapeutics raised

Funding, as reported

Reported in all **9M** in the source's currency

Rounds **2**

Last round **Series unknown**

Last round size **9M**

Last round date **Nov 2024**

## Founders and team

From Aurealis Therapeutics's own website: 12 on the team.

- **Juha Yrjänheikki** CEO
- **Hanna P. Lesch** CTO
- **Laurent Décory** COO
- **Hanna-Riikka Kärkkäinen** Director of Quality & Regulatory Affairs
- **Jean De Gunzburg** Board Director
- **Jere Kurkipuro** Senior Director R&D Operations
- **Maija Rusi** Financial & Administrative Director
- **Matleena Piiroinen** Senior Drug Safety Officer
- **Mirka Sanio** Clinical Operations Director
- **Roger Meier** Chairman of the
- **Silvio Inderbitzin** Board Director
- **Tuomo Pätsi** Board Director

Advisers *Alberto Piaggesi* *David Armstrong* *Kirsi Isoherranen*

## The company, in detail

What they build

Known for

oncology biotechnology research oncolytic bacteria chronic wounds cell gene therapy inflammation b2b hospital & health care advanced therapy medicinal product recombinant live biotherapeutic

Built with from their website

Google Maps Google Tag Manager Priority Hints Google Font API WordPress.org Instagram imagesLoaded Microsoft Exchange Nginx Microsoft 365

+8 more

Font Awesome MySQL Elementor YouTube Outlook Microsoft 365 Apps & Services PHP Viewport Meta

- **Sector:** Research
- **Industry code:** NAICS 541714, 325414
- **Revenue:** 3M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/aurealis-therapeutics)

## Research in Finland

Startups like it

- [**TILT Biotherapeutics Ltd** Helsinki · founded 2013](https://millionrounds.com/startup/tilt-biotherapeutics-ltd)
- [**Enifer** Espoo · founded 2020](https://millionrounds.com/startup/enifer-2)
- [**Volare Solutions** Helsinki · founded 2021](https://millionrounds.com/startup/volare-solutions)
- [**Valo Therapeutics Ltd** Helsinki · founded 2016](https://millionrounds.com/startup/valo-therapeutics-ltd)
- [**Linio Biotech** Helsinki · founded 2017](https://millionrounds.com/startup/linio-biotech)
- [**Boreal Bioproducts** Espoo · founded 2018](https://millionrounds.com/startup/boreal-bioproducts)
- [**KÄÄPÄ Biotech** Lohja · founded 2018](https://millionrounds.com/startup/k-p-biotech-2)
- [**Rappta Therapeutics** Helsingfors · founded 2019](https://millionrounds.com/startup/rappta-therapeutics)

## Is this your company?

Add your raise, your deck and your story, and put Aurealis Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)